Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-10 · accession 0001573785-22-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-12 | 2022-01-10 | LSTA | Davidson Michael H. | Dir | A - Grant | $0.00 | +65.4K | 209.8K | +45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-10 | A | A | 65,430 | $0.00 | 209,753 | D | — | — | (F1) Represents 65,430 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 10, 2023. (F2) Includes 137,207 unvested restricted stock units. |